Primary cutaneous SMARCA4-deficient undifferentiated malignant neoplasm: first two cases with clinicopathologic and

Eleanor Russell-Goldman1, Laura MacConaill2, John Hanna2

  • 1Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. erussell-goldman@bwh.harvard.edu.

Insights

This study reports the first cases of primary cutaneous SMARCA4-deficient undifferentiated malignant neoplasms (SD-UMN), aggressive tumors previously unrecognized in the skin. These findings expand the known locations for SD-UMN, aiding diagnosis and treatment.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • SMARCA4-deficient undifferentiated malignant neoplasms (SD-UMN) are aggressive tumors characterized by SMARCA4 gene mutations.
  • These neoplasms were initially identified in the thoracic cavity but have since been found in various visceral locations.

Observation:

  • This study presents the first two cases of primary cutaneous SD-UMN.
  • Clinical, radiological, and molecular analyses supported a skin origin, with evidence of UV-associated mutations.
  • The cutaneous tumors exhibited similar morphological, immunohistochemical, and molecular characteristics to visceral SD-UMN.

Findings:

  • Both cutaneous SD-UMN cases demonstrated biallelic inactivation of SMARCA4, TP53, and CDKN2A.
  • These genetic alterations are also frequently observed in visceral SD-UMN.
  • The aggressive nature of the tumor was highlighted by one patient's rapid disease progression.

Implications:

  • The findings expand the anatomical spectrum of SD-UMN, including the skin.
  • Accurate diagnosis is crucial for differentiating SD-UMN from other skin cancers like melanoma and Merkel cell carcinoma.
  • Timely diagnosis impacts patient prognosis and therapeutic strategies for this aggressive neoplasm.